Correlation Between Opus Genetics, and Encision

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Opus Genetics, and Encision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Genetics, and Encision into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opus Genetics, and Encision, you can compare the effects of market volatilities on Opus Genetics, and Encision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Genetics, with a short position of Encision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Genetics, and Encision.

Diversification Opportunities for Opus Genetics, and Encision

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Opus and Encision is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Opus Genetics, and Encision in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Encision and Opus Genetics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Genetics, are associated (or correlated) with Encision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Encision has no effect on the direction of Opus Genetics, i.e., Opus Genetics, and Encision go up and down completely randomly.

Pair Corralation between Opus Genetics, and Encision

Considering the 90-day investment horizon Opus Genetics, is expected to under-perform the Encision. In addition to that, Opus Genetics, is 1.47 times more volatile than Encision. It trades about -0.02 of its total potential returns per unit of risk. Encision is currently generating about -0.01 per unit of volatility. If you would invest  50.00  in Encision on September 29, 2024 and sell it today you would lose (6.00) from holding Encision or give up 12.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy27.22%
ValuesDaily Returns

Opus Genetics,  vs.  Encision

 Performance 
       Timeline  
Opus Genetics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Opus Genetics, is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
Encision 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Encision has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Encision is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Opus Genetics, and Encision Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Opus Genetics, and Encision

The main advantage of trading using opposite Opus Genetics, and Encision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Genetics, position performs unexpectedly, Encision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Encision will offset losses from the drop in Encision's long position.
The idea behind Opus Genetics, and Encision pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.